{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:34:06Z","timestamp":1759332846215},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T00:00:00Z","timestamp":1256688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1752-1947-3-84","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T07:34:57Z","timestamp":1256888097000},"source":"Crossref","is-referenced-by-count":4,"title":["Long-term remission of myopic choroidal neovascular membrane after treatment with ranibizumab: a case report"],"prefix":"10.1186","volume":"3","author":[{"given":"Neruban","family":"Kumaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn A","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Tufail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,28]]},"reference":[{"key":"900_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1444-0938.2003.tb03122.x","volume":"86","author":"T Grosvenor","year":"2003","unstructured":"Grosvenor T: Why is there an epidemic of myopia?. Clin Exp Optom. 2003, 86: 273-275. 10.1111\/j.1444-0938.2003.tb03122.x.","journal-title":"Clin Exp Optom"},{"key":"900_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1755-3768.1988.tb02673.x","volume":"185","author":"E Goldschmidt","year":"1988","unstructured":"Goldschmidt E: Ocular morbidity in myopia. Acta Ophthalmol Suppl. 1988, 185: 86-87. 10.1111\/j.1755-3768.1988.tb02673.x.","journal-title":"Acta Ophthalmol Suppl"},{"key":"900_CR3","volume-title":"System of Ophthalmology. St. Louis, Mosby","author":"S Duke-Elder","year":"1970","unstructured":"Duke-Elder S: Pathological refractive errors. System of Ophthalmology. St. Louis, Mosby. 1970, V:"},{"key":"900_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0161-6420(02)01094-1","volume":"109","author":"MC Leske","year":"2002","unstructured":"Leske MC, Wu SY, Nemesure B, Hennis A, Barbados Eye Studies Group: Risk factors for incident nuclear opacities. Ophthalmology. 2002, 109: 1303-1308. 10.1016\/S0161-6420(02)01094-1.","journal-title":"Ophthalmology"},{"issue":"5","key":"900_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1475-1313.2005.00298.x","volume":"25","author":"Seang-Mei Saw","year":"2005","unstructured":"Saw Seang-Mei, Gazzard Gus, Shih-Yen Chan Edwin, Chua Wei-Han: Myopia and associated pathological complications. Ophthalmic & physiological optics: the journal of the British College of Ophthalmic Opticians (Optometrists). 2005, 25 (5): 381-391.","journal-title":"Ophthalmic & physiological optics: the journal of the British College of Ophthalmic Opticians (Optometrists)"},{"key":"900_CR6","first-page":"844","volume":"82","author":"S Resnikoff","year":"2004","unstructured":"Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajsegaram R, Pokarel G, Mariotti S: Global data on visual impairment in the year 2002. Bull World Health Organ. 2004, 82: 844-851.","journal-title":"Bull World Health Organ"},{"key":"900_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00004397-199030030-00009","volume":"30","author":"DS Fong","year":"1990","unstructured":"Fong DS, Epstein DL, Allingham RR: Glaucoma and myopia: are they related?. Int Ophthalmol Clin. 1990, 30: 215-218. 10.1097\/00004397-199030030-00009.","journal-title":"Int Ophthalmol Clin"},{"issue":"2","key":"900_CR8","first-page":"67","volume":"46","author":"NS Bhatt","year":"1998","unstructured":"Bhatt NS, Diamond JG, Jalali S, Das T: Choroidal neovascular membrane. Indian J Ophthalmol. 1998, 46 (2): 67-80.","journal-title":"Indian J Ophthalmol"},{"key":"900_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","volume":"161","author":"N Ferrara","year":"1989","unstructured":"Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989, 161: 851-858. 10.1016\/0006-291X(89)92678-8.","journal-title":"Biochem Biophys Res Commun"},{"key":"900_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N, Lowman H, Kim R: Development of Ranibizumab, and anti-vascularendothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina. 2006, 26: 859-870. 10.1097\/01.iae.0000242842.14624.e7.","journal-title":"Retina"},{"key":"900_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bjo.2006.096776","volume":"91","author":"I Yamamoto","year":"2007","unstructured":"Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS: Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol. 2007, 91: 157-160. 10.1136\/bjo.2006.096776.","journal-title":"Br J Ophthalmol"},{"key":"900_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/bjo.2006.099887","volume":"91","author":"H Sakaguchi","year":"2007","unstructured":"Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y: Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol. 2007, 91: 161-165. 10.1136\/bjo.2006.099887.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"900_CR13","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.ophtha.2007.03.043","volume":"114","author":"WM Chan","year":"2007","unstructured":"Chan WM, Lai TY, Liu DT, Lam DS: Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. Ophthalmology. 2007, 114 (12): 2190-2196. 10.1016\/j.ophtha.2007.03.043.","journal-title":"Ophthalmology"},{"key":"900_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/bjo.2008.145391","volume":"93","author":"JM Ruiz-Moreno","year":"2009","unstructured":"Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Ares S, Lopez-Lopez F, Rodriguez M, Fernandez M: Intravitreal bevacizumab to treat subfoveal choroidal neovascularization in highly myopic eyes:1 year outcome. Br J Ophthalmol. 2009, 93: 448-451. 10.1136\/bjo.2008.145391.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"900_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/IAE.0b013e31817eda41","volume":"28","author":"RM Silva","year":"2008","unstructured":"Silva RM, Ruiz-Moreno JM, Nascimento J, Carneiro A, Rosa P, Barbosaa A, Carvalheira F, Abreu JR, Cunha-Vaz JG: Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization. Retina. 2008, 28 (8): 1117-1123. 10.1097\/IAE.0b013e31817eda41.","journal-title":"Retina"},{"issue":"3","key":"900_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00417-008-0995-0","volume":"247","author":"L Konstantinidis","year":"2009","unstructured":"Konstantinidis L, Mantel I, Pournaras JA, Zografos L, Ambresin A: Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2009, 247 (3): 311-318. 10.1007\/s00417-008-0995-0.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"14","key":"900_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group: Ranibizumab for neovascular age-related macular degeneration: 2-year results of the MARINA study. N Engl J Med. 2006, 355 (14): 1419-1431. 10.1056\/NEJMoa054481.","journal-title":"N Engl J Med"},{"key":"900_CR18","first-page":"41","volume-title":"Retina Today","author":"HE Grossniklaus","year":"2007","unstructured":"Grossniklaus HE, Green WR: All About PrONTO: Study Yielded Good Results in AMD With Treatment Guided by OCT MAY\/JUNE. Retina Today. 2007, 41-48."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-3-84\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-3-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-3-84","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-3-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T02:56:46Z","timestamp":1548125806000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-3-84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,28]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-3-84","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,28]]},"article-number":"84"}}